| ||||||||||||||
|
|
|||||||||||||

*Department of Anaesthesiology and Intensive Care Medicine and
Department of Surgery, Biomedical Engineering and Computing Unit, Faculty of Medicine, Karl-Franzens University, Graz, Austria
Address correspondence and reprint requests to Ashraf A. Dahaba, MD, MSc, PhD, Department of Anaesthesiology and Intensive Care Medicine, Faculty of Medicine, Karl-Franzens University, Auenbruggerplatz 29, A-8036, Graz, Austria. Address e-mail to ashraf.dahaba{at}meduni-graz.at
| Abstract |
|---|
|
|
|---|
IMPLICATIONS: The bispectral index (BIS) and its new version, the BIS-XP, monitor the depth of anesthesia. Under propofol/remifentanil anesthesia, the BIS readings did not significantly change during complete neuromuscular block or during various levels of neuromuscular recovery.
| Introduction |
|---|
|
|
|---|
The results of two recent peer-reviewed studies seem to be confusing. The first study (2) showed that, in paid volunteers, neuromuscular blocking drugs (NMBDs) had no effect on BIS monitoring. Conversely, the second study (3) showed that in intensive care unit (ICU) sedated patients, NMBDs caused a marked decline in BIS. Adding to the confusion, authors of a recent study (4) volunteered to self-administer NMBD while fully awake and reported a BIS decline to a value of as low as 9. The BIS algorithm was derived from more than 5000 subjects to correlate with the depth of general anesthesia in the operating room (1) and was not intended for sedated ICU patients or for awake volunteers. No controlled study has appeared in literature specifically examining the effect of neuromuscular block on BIS monitoring in a real operating room setting under deep surgical levels of anesthesia.
The purpose of our study was to assess, in patients undergoing general surgical procedures under propofol/remifentanil anesthesia, the effect of mivacurium chloride 0.15 mg/kg (twice the 95% effective dose) neuromuscular block on BIS monitoring and to compare the conventional A-2000 BISTM (BIS3.4) with the new BIS-XPTM (BISXP) monitors (Aspect Medical Systems, Newton, MA).
| Methods |
|---|
|
|
|---|
Neuromuscular function at the adductor pollicis muscle was evaluated with the RelaxometerTM (Groningen University, Groningen, Holland) mechanomyograph (MMG) (9). The force transducer was attached to the thumb, with the preload maintained between 200 and 400 g. After the induction of anesthesia, the ulnar nerve was stimulated supramaximally at the wrist (pulse width, 200 µs; square wave) with train-of-four (TOF) stimuli (2 Hz for 2 s) at 12-s intervals. The MMG was connected to a laptop computer via the serial port. Data were continuously collected and recorded with the AZG-Relaxometer 5.0 program until all patients fully recovered from neuromuscular block. T1 (first twitch of the TOF) expressed as a percentage of the control response and the TOF ratio (T4:T1) were used for the evaluation of neuromuscular block. The possible contamination of BIS signal by the continuous 12-s TOF stimulation was excluded because a regular 12-s artifact signal did not appear in the BIS tracings.
No electric or forced-air warming devices that could have caused false BIS readings (10) were used in our study. Both monitors were alternatively placed on the left and right sides in consecutive patients to level out any effect of dominance of one cerebral hemisphere. A conventional BIS3.4 three-electrode (1, 2, and 3) sensor and the new BISXP four-electrode (1, 2, 4, and 3) sensor were simultaneously placed, one on each side. The BIS3.4 sensor strip was transversely placed on the forehead with electrode 1 in the midline and then connected to a conventional BIS3.4 monitor (software Version 3.4). The displayed BIS3.4 value was the combined impedance of electrodes 1 and 3. The BISXP sensor has a completely different montage, because its sensor strip is not placed transversely but has to be inclined on the forehead for the new electrode 4 to be placed slanting just above the eyebrow. This sloping montage allowed the BIS3.4 and BISXP midline electrodes to be simultaneously placed with the BISXP midline electrode slightly higher on the forehead than the BIS3.4 midline electrode, as demonstrated in Figure 1. The BISXP sensor was connected to a BISXP monitor (software Version 4.0). The displayed BISXP value was the combination of the lowest values of Channel 1 derived from electrodes 1 and 3 and Channel 2 (BISXP CH2) derived from electrodes 1 and 4.
|
. The BIS3.4 and BISXP monitors were separately connected to two laptop computers by using the serial port capture technique. Data were continuously collected and stored in the once-every-5-s mode. Before starting, all 3 clocks of BIS3.4, BISXP, and MMG were precisely synchronized. Oral midazolam 7.5 mg was administered 1 h before surgery. For induction, a remifentanil 0.150.3 µg · kg1 · min1 infusion and a propofol target-controlled infusion (TCI) with a DiprifusorTM infusion pump (AstraZeneca, Cheshire, UK) were started. After the patients anthropometric data were entered, propofol TCI was set to reach an effect-site concentration of 4 µg/mL over 4 min, during which patients were allowed to breathe spontaneously via a face mask. When the eyelash reflex was obtunded, a laryngeal mask airway (LMA) was inserted. After verification of the proper positioning of the LMA and complete respiratory drive suppression, patients lungs were mechanically ventilated with 40% oxygen in air.
A stable BIS of approximately 40 was recommended as deep surgical anesthesia level with the same anesthesia regimen we used in our study (11). Anesthesia of a stable BIS3.4 of approximately 40 was subsequently maintained via propofol TCI with ±0.2 µg/mg rate adjustments. The Diprifusors three-compartment pharmacokinetic algorithm (software Version 2) calculates the required plasma concentration and adjusts the propofol infusion rate accordingly; this proved to accurately correlate with BIS (12). The last propofol TCI rate was recorded and maintained with no further adjustments from the start of a 0.15 mg/kg (twice the 95% effective dose) mivacurium administration until full neuromuscular recovery (100% T1 recovery). Mivacuriums complete but short neuromuscular block rendered less likely the possibility of changes in surgical conditions during myorelaxation that would confound BIS monitoring. Hypotension was managed by hydroxyethyl starch 130/0.4 infusion and by increasing the crystalloid fluid infusion. Patients requiring exogenous catecholamines administration, such as ephedrine (1025 mg) or phenylephrine (50100 µg), were excluded from the study because exogenous catecholamines were shown to evoke a change in BIS readings (13,14). At the end of surgery, propofol and remifentanil infusions were discontinued, and the patients were allowed to breathe spontaneously. When patients could open their eyes in response to verbal command, the LMA was removed, and patients were discharged.
On the basis of the first 10 pilot patients, our a priori power calculation (
= 0.05), with the primary variable to be the difference between the mean BIS3.4 value before mivacurium administration and the highest BIS3.4 value reached during the mivacurium onset phase, showed that 30 patients would be required to reveal a statistically significant difference with >95% power. Repeated-measures analysis of variance was used to analyze the effect of mivacurium onset on BIS3.4 and BISXP. Paired Students t-tests were used to analyze the differences between monitors and to compare the two monitors biases at different phases. Data were expressed as mean ± SD; P < 0.05 was considered statistically significant.
Data collected from the two monitors were additionally analyzed on the basis of the statistical method of Bland and Altman (15), which does not consider the BIS3.4 or BISXP to be the true standard method for depth of anesthesia monitoring but rather assumes that both monitors are subject to experimental error. Bias defines the mean of the difference between the two monitors. Limits of agreement define the bias ± 1.96 SD, in which 95% of the differences between monitors are expected to lie.
| Results |
|---|
|
|
|---|
and 1.4 ± 0.3 k
, respectively, indicating optimal electrode placement throughout our study. Patients mean age was 49.7 ± 8.2 yr, and the mean weight was 75 ± 12 kg. The predicted propofol effect-site concentration was 3.61 ± 0.6 µg/mL. The mean duration from anesthesia induction until establishment of a stable BIS3.4 of approximately 40 was 6.8 ± 2.4 min. At all phases, BISXP was constantly lower than BIS3.4 (P = 0.001). BISXP CH2 was constantly closer to BIS3.4 than to BISXP, and this is why BISXP CH2 was not shown in our figures, because it almost overlapped the BIS3.4 tracings. The response to mivacurium administration was a transient BIS3.4 increase from 43 ± 4 to 49 ± 7 (P = 0.007) and a BISXP decline from 41 ± 3 to 35 ± 3 (P = 0.003) at 1 ± 0.2 min (Fig. 2). After 2.5 ± 1 min after mivacurium administration, BIS3.4 and BISXP returned to baseline values of 43 ± 5 and 40 ± 4, respectively.
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
In an attempt to explain the peculiar divergence in response between BIS3.4 and BISXP, we can only speculate that the phenomenon of two monitors manifesting the same artifact in two opposite mirror images arises from the different nature of two artifact-recognition algorithms. The BISXP CH2 acquires information from the new fourth above-eyebrow electrode, thus viewing the same signal from a completely new plane. According to the manufacturer, the BISXP artifact-recognition algorithm recognizes an artifact from its asymmetry with what they called its BISXP CH2 mirror image. In our study patients, it seemed that while the conventional BIS3.4 monitor was presenting an artifact in its raw form (an increase), the BISXP displayed its BISXP CH2 mirror image (a decline).
High EMG activity in response to surgical stimulation could be misinterpreted by the BIS algorithm as EEG activity and assigned spuriously increased BIS values, making deeply anesthetized patients appear more awake than they really are (19). In our study patients, surgical deep anesthesia levels of BIS 40 and adequate remifentanil analgesia (20) prevented any EMG activity from contaminating or compromising the BIS3.4 and BISXP values. This is why BIS3.4 and BISXP readings did not significantly change during complete neuromuscular block or during various levels of neuromuscular recovery.
Greif et al. (2) showed that under TCI propofol infusion, neither BIS nor EMG was altered by randomly allocated mivacurium neuromuscular block levels. This is in accordance with our study and demonstrates that in the absence of noxious stimuli in paid volunteers (and, hence, no EMG activity artifactually increasing BIS), mivacurium had no effect on BIS monitoring.
Vivien et al. (3) examined 45 ICU patients sedated with midazolam and sufentanil to a Sedation Agitation Scale score of 1. BIS (67 ± 19) and EMG (37 ± 9 dB) significantly declined with atracurium administration in the lightly sedated patients, whereas there was no change in BIS among the 13 deeply sedated patients with minimal EMG activity. This clearly indicates that in most patients in the Vivien et al. (3) study, the doses used were totally inadequate to achieve the deep sedation and analgesia that would have abolished EMG activity. When the same anesthetic regimen of midazolam and sufentanil for cardiac surgery was used (21), the dose of sufentanil required to achieve BIS 50 and BIS 40 was reported to be 5.5 and 8.5 times larger, respectively, than the dose used in the Vivien et al. (3) study.
Another factor that could have confounded the Vivien et al. (3) study is the fact that BIS simply does not correlate with any of the ICU sedation scores and that interindividual BIS values vary widely, even among patients at the deepest level of ICU sedation scores (2225). This was not the case in our study patients, who were all maintained at a stable BIS value of 40 at the time of NMBD administration. BIS was not derived from data collected from ICU patients but rather was developed from a large database of anesthetized subjects to correlate with the depth of anesthesia in the operating room. This does not necessary apply to critically ill patients sedated in an ICU setting (25).
The wide BIS3.4/BISXP bias indicates a basic inherent difference between the BIS3.4 and BISXP algorithms. The fact that arousal (Table 2) at the anesthesia recovery phase further widened the bias (P = 0.009) emphasizes that with more EEG activity the two algorithms act differently, driving the two systems even further apart. In another situation, the high bias and wide limits of agreement of the mivacurium onset-phase artifacts were significantly narrowed (P = 0.011) by complete neuromuscular block and neuromuscular recovery after the abolishment of the artifacts, leaving just the basic difference between the two monitors.
The manufacturers correlation coefficient of BISXP 4.0 versus BIS3.4 was 0.963. This merely shows that the two systems were highly correlated in the manufacturers 2563 test volunteers but does not inform us of the inherent differences between the two monitors or of how the two systems somehow act differently in different situations.
BISXP CH2 represents data acquired from the new fourth above-eyebrow electrode that views the same signal from a new plane. Interestingly enough, at all phases in our study, the raw BISXP CH2 of the BISXP monitor was constantly closer and almost identical to that of the conventional BIS3.4 monitor rather than its own BISXP. This shows that the data acquired with the two systems, although originating from different electrodes, were still virtually identical. The bias appears only after the two algorithms process these acquired data in a different fashion.
Our study indicated that during deep surgical propofol/remifentanil anesthesia, the onset of neuromuscular block triggered a brief transient odd divergence response that manifested as a BIS3.4 increase and BISXP decline that lasted until relaxation was complete. After that, BIS3.4 and BISXP did not significantly change during complete neuromuscular block or during various levels of neuromuscular recovery. The BIS3.4/BISXP bias and wide limits of agreement do not allow values given by the two monitors to be used interchangeably for individual patients.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C.-H. Lu, K.-M. Man, H.-Y. Ou-Yang, S.-M. Chan, S.-T. Ho, C.-S. Wong, and W.-J. Liaw Composite Auditory Evoked Potential Index Versus Bispectral Index to Estimate the Level of Sedation in Paralyzed Critically Ill Patients: A Prospective Observational Study Anesth. Analg., October 1, 2008; 107(4): 1290 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bonhomme and P. Hans Muscle relaxation and depth of anaesthesia: where is the missing link? Br. J. Anaesth., October 1, 2007; 99(4): 456 - 460. [Full Text] [PDF] |
||||
![]() |
M. T. V. Chan and T. Gin Changes of bispectral index after a bolus dose of muscle relaxant. Anesth. Analg., September 1, 2006; 103(3): 776 - 777. [Full Text] [PDF] |
||||
![]() |
N. Liu, T. Chazot, I. Huybrechts, J.-D. Law-Koune, L. Barvais, and M. Fischler The Influence of a Muscle Relaxant Bolus on Bispectral and Datex-Ohmeda Entropy Values During Propofol-Remifentanil Induced Loss of Consciousness Anesth. Analg., December 1, 2005; 101(6): 1713 - 1718. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Dahaba Different Conditions That Could Result in the Bispectral Index Indicating an Incorrect Hypnotic State Anesth. Analg., September 1, 2005; 101(3): 765 - 773. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|